Avian Influenza Vaccines Market: By Strain Type, By Vaccine Type, By Application Type, and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Avian Influenza Vaccines Market Size, Share, Growth, Trends, and Global Industry Analysis: By Strain Type (Type H9, Type H7, Type H5 and Others), By Vaccine Type (Live Recombinant Vaccines, Inactivated Vaccines and Combination Vaccines), By Application Type (Duck & Goose, Chicken and Others), and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Avian Influenza Vaccines Market size was valued at US$ 149.0 million in 2023 and is poised to grow at a CAGR of 4.9% from 2024-2030. Avian influenza, commonly known as bird flu, is a viral virus that transmits from birds to other animals including people. There are other forms of avian influenza that cause infection, but H5V1 is the most frequent viral strain that affects poultry. Based on strain type, the market is segmented into type H9, type H7, type H5, and Others. H5 is the most common virus strain segment and holds most of the market share in the global influenza vaccine market. The majority of A(H5) viruses seen in wild birds and poultry are LPAI,

However, HPAI A(H5) viruses have also been found. Human infections with A(H5) viruses have been reported sporadically, such as with HPAI A(H5N1) viruses linked to poultry epidemics in various countries across the globe. For instance, in March 2022, highly pathogenic avian influenza A(H5N1) viruses (H5N1 bird flu viruses) have been detected in USA wild birds in 14 states. Increasing government initiatives to raise awareness about avian influenza among the farmers, rise in private-sector financing for the development of effective avian influenza vaccines, and increased poultry bird production are expected to contribute to the market growth.

Key Developments

  • In October 2019, Ceva and ProBioGen AG signed an exclusive license agreement for the manufacture of vectorized poultry vaccines using ProBioGen's proprietary AGE1.CR technology.
  • In October 2018, Boehringer Ingelheim announced the opening of its biological research and development site in France. It invested US$ 80.45 million (EUR 70 million) for maintaining its leading position in veterinary vaccines.

summary download arrow Download Free Sample

Avian Influenza Vaccines Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.2%

Largest Market

North America

Fastest Growing Market

Asia-Pacific

Avian Influenza Vaccines Market Dynamics

The industry is likely to offer significant opportunities as a result of an increase in public and private initiatives by the government and non-government organizations for research and development activities. For instance, In February 2018, the NC State College of Veterinary Medicine and Ceva Santa Animale, a French animal health organization, engaged on a distance learning project to provide certification in poultry health management to veterinarians in Latin America.

Avian Influenza Vaccines Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 149.0 million

Market CAGR

4.2%

By Strain Type

  • Type H9
  • Type H7
  • Type H5
  • Others

By Vaccine Type

  • Live Recombinant Vaccines
  • Inactivated Vaccines
  • Combination Vaccines

By Application Type

  • Duck & Goose
  • Chicken
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The avian influenza vaccine market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global avian influenza vaccines market size was valued at US$ 149.0 million in 2023 and is poised to grow at a CAGR of 4.9% from 2024-2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The key players of the report are CEVA, FATRO, Biken, HVRI, Merial, Merck, Zoetis, Elanco, Avimex Laboratories.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Avian Influenza Vaccines Market Introduction 
2.1.Global Avian Influenza Vaccines Market  - Taxonomy
2.2.Global Avian Influenza Vaccines Market  - Definitions
2.2.1.Strain Type
2.2.2.Vaccine Type
2.2.3.Application Type
2.2.4.Region
3.Global Avian Influenza Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Avian Influenza Vaccines Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Avian Influenza Vaccines Market  By Strain Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Type H9
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Type H7
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Type H5
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Avian Influenza Vaccines Market  By Vaccine Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Live Recombinant Vaccines
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Inactivated Vaccines
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Combination Vaccines
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Avian Influenza Vaccines Market  By Application Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Duck & Goose
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Chicken
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Avian Influenza Vaccines Market  By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Avian Influenza Vaccines Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Strain Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Type H9
9.1.2.Type H7
9.1.3.Type H5
9.1.4.Others
9.2.  Vaccine Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Live Recombinant Vaccines
9.2.2.Inactivated Vaccines
9.2.3.Combination Vaccines
9.3.  Application Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Duck & Goose
9.3.2.Chicken
9.3.3.Others
9.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Avian Influenza Vaccines Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Strain Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Type H9
10.1.2.Type H7
10.1.3.Type H5
10.1.4.Others
10.2.  Vaccine Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Live Recombinant Vaccines
10.2.2.Inactivated Vaccines
10.2.3.Combination Vaccines
10.3.  Application Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Duck & Goose
10.3.2.Chicken
10.3.3.Others
10.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Avian Influenza Vaccines Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Strain Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Type H9
11.1.2.Type H7
11.1.3.Type H5
11.1.4.Others
11.2.  Vaccine Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Live Recombinant Vaccines
11.2.2.Inactivated Vaccines
11.2.3.Combination Vaccines
11.3.  Application Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Duck & Goose
11.3.2.Chicken
11.3.3.Others
11.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Avian Influenza Vaccines Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. Strain Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Type H9
12.1.2.Type H7
12.1.3.Type H5
12.1.4.Others
12.2.  Vaccine Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Live Recombinant Vaccines
12.2.2.Inactivated Vaccines
12.2.3.Combination Vaccines
12.3.  Application Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Duck & Goose
12.3.2.Chicken
12.3.3.Others
12.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Avian Influenza Vaccines Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
13.1. Strain Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Type H9
13.1.2.Type H7
13.1.3.Type H5
13.1.4.Others
13.2.  Vaccine Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Live Recombinant Vaccines
13.2.2.Inactivated Vaccines
13.2.3.Combination Vaccines
13.3.  Application Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Duck & Goose
13.3.2.Chicken
13.3.3.Others
13.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.CEVA
14.2.2.FATRO
14.2.3.Biken
14.2.4.HVRI
14.2.5.Merial
14.2.6.Merial
14.2.7.Merck
14.2.8.Zoetis
14.2.9.Elanco
14.2.10.Avimex Laboratories
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • CEVA
  • FATRO
  • Biken
  • HVRI
  • Merial
  • Merial
  • Merck
  • Zoetis
  • Elanco
  • Avimex Laboratories

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market